BioSpace News Archive

Drug Development

ESMO 2019: CStone presents pooled safety data from the Phase 1b trial of CS1001, demonstrating promising overall safety and tolerability

CStone Pharmaceuticals released pooled safety data from the Phase Ib study of the Company’s anti-PD-L1 antibody CS1001 in a poster presentation at the European Society of Medical Oncology 2019 Congress, demonstrating the promising safety and tolerability profile of CS1001.

September 30, 2019
·
6 min read
Deals

Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag™

Medicure Inc., a cardiovascular pharmaceutical company, is pleased to announce that through its subsidiary, Medicure International Inc., it has acquired the ownership of ZYPITAMAGTM tablets, from Cadila Healthcare Ltd., India for US and Canadian markets.

September 30, 2019
·
8 min read
Deals

Immunic, Inc. to Participate in Investor and Scientific Conferences in October

Immunic, Inc. announced management’s participation in the following investor and scientific conferences in October

September 30, 2019
·
5 min read
Pharm Country

Merck to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

Merck, known as MSD outside the United States and Canada, announced that Michael Nally, Chief Marketing Officer for Merck, is scheduled to present during a fireside chat at the Cantor Fitzgerald 2019 Annual Global Healthcare Conference in New York on Wednesday, Oct. 2, at 2:25 p.m. EDT.

September 30, 2019
·
3 min read
BioMidwest

Sovateltide (PMZ-1620), an Endothelin-B receptor Agonist, has the potential to be a first-in-class neuronal progenitor cell therapeutics

Pharmazz, Inc. announced that it made 5 presentations at the Sixteenth International Conference on Endothelin held in Kobe, Japan from September 22nd to 25th, 2019.

September 30, 2019
·
3 min read
Deals

Gryphon Investors Announces Pending Sale of ECG Management Consultants

Gryphon Investors, a San Francisco-based middle-market private equity firm, announced that it has entered definitive documentation to sell its portfolio company ECG Management Consultants to Siemens Medical Solutions USA, Inc., a subsidiary of Siemens Healthineers AG.

September 30, 2019
·
2 min read
Deals

CKHH Aims to Deconsolidate Chi-Med and to Hold as a Strategic Investment for the Long Term

CK Hutchison Holdings Limited announces its intention to sell approximately 1.3% of the total outstanding share capital in Hutchison China MediTech Limited through an underwritten public offering, which would reduce its stake in Chi-Med from 51.1% to 49.9%.

September 30, 2019
·
2 min read
Drug Development

Ayala Pharmaceuticals Presents Encouraging Preliminary Safety and Efficacy Data in Patients with Recurrent/Metastatic Adenoid Cystic Carcinoma with Progressing Disease and Notch Activating Mutations from Ongoing Phase 2 Clinical Trial at ESMO

22% Response Rate; 61% Disease Control Observed

September 30, 2019
·
6 min read
BiomX Presents In Vivo Data on Bacteriophage Delivery to Intra-Tumor Bacteria

BiomX Ltd. presented new data from the company’s colorectal cancer synthetic biology program at the Fifth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference in Paris, France.

September 30, 2019
·
2 min read
Business

Poul Sorensen Receives the 2019 Bloom Burton Award

Bloom Burton & Co. is pleased to announce Dr. Poul Sorensen as the recipient of the 2019 Bloom Burton Award.

September 30, 2019
·
3 min read